Exelixis Clinical Site #103

Milan 20133

0 studies enrolling now · 2 studies all time

What they study most

Castration-resistant Prostate Cancer, Colorectal Cancer, Differentiated Thyroid Cancer, Endometrial Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Hepatocellular Carcinoma, Lower Esophageal Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Renal Cell Carcinoma

Studies at this site

• A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy — Running, not enrolling
• Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling